Comparative Risk of Serious Infections with Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis

BACKGROUND AND AIMS: We performed a systematic review and meta-analysis to evaluate the comparative risk of serious infections with tumor necrosis factor-α (TNFα) antagonists, biologic agents that do not inhibit TNFα, tofacitinib, and immunosuppressive agents in inflammatory bowel diseases (IBD). ME...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Gastroenterol Hepatol
Päätekijät: Singh, Siddharth, Facciorusso, Antonio, Dulai, Parambir S., Jairath, Vipul, Sandborn, William J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011651/
https://ncbi.nlm.nih.gov/pubmed/30876964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2019.02.044
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia